Tuhi Life Sciences Private Limited
About Tuhi Life Sciences Private Limited
Data last updated:
Tuhi Life Sciences Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U74999MP2017PTC044531. Its GSTIN is 23AAGCT5126R1ZX (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satvinder Kaur and Gurpreet Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 86/1 Agrawal Nagar, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹78.19 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹64,840 (net margin 0.8%) and EBITDA of ₹1.31 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address86/1 Agrawal Nagar, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Tuhi Life Sciences Private Limited
The main business activities of Tuhi Life Sciences are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Tuhi Life Sciences Private Limited FY 2025 filings available
Tuhi Life Sciences Private Limited reported revenue of ₹78.19 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Tuhi Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 11% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Tuhi Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.31 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹64,840 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Tuhi Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Tuhi Life Sciences are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Tuhi Life Sciences Private Limited
Tuhi Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synergy Biopharma P Ltd | ₹78.84 Lakh (FY 2025) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Vittarthaa Life Sciences Private Limited | ₹78.8 Lakh (FY 2025) | •••• | •••• | -37.0% | •••• | Bangalore, Karnataka, India |
| Century Drugs Private Limited | ₹78.63 Lakh (FY 2025) | •••• | •••• | -82.0% | •••• | Pithampur, Madhya Pradesh, India |
| Cedimed Life Science Private Limited | ₹78.28 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Cheruthuruthy, Kerala, India |
| Hyderabad Medicine Private Limited | ₹78.25 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Tuhi Life Sciences Private Limited this company | ₹78.19 Lakh (FY 2025) | •••• | •••• | 11.0% | •••• | Indore, Madhya Pradesh, India |
| Faith Pharmaceuticals Limited | ₹78.18 Lakh (FY 2025) | •••• | •••• | 4.0% | •••• | New Delhi, Delhi, India |
| Pharm Biosis Private Limited | ₹77.86 Lakh (FY 2022) | •••• | •••• | 613.0% | •••• | Ahmedabad, Gujarat, India |
| Nuak Laboratories Pvt Ltd | ₹77.61 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Paraganas, West Bengal, India |
| Novaarc Surgicals Private Limited | ₹77.58 Lakh (FY 2021) | •••• | •••• | -48.0% | •••• | Bengaluru, Karnataka, India |
| Leogen Biotics Private Limited | ₹77.43 Lakh (FY 2024) | •••• | •••• | 93.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Tuhi Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Tuhi Life Sciences Private Limited
Tuhi Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satvinder Kaur Also directs: Bizmac Healthcare Private Limited | Director | 20 Nov 2017 | 8 Years 10 Months | Current |
| Gurpreet Singh Also directs: Bizmac Healthcare Private Limited | Director | 01 Jun 2025 | 1 Years 4 Months | Current |
Ownership and Shareholding of Tuhi Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Tuhi Life Sciences Private Limited
Tuhi Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Tuhi Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Tuhi Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Tuhi Life Sciences Private Limited
Tuhi Life Sciences Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Gurpreet Singh ceased to be Additional Director on 29 Sep 2025.
Credit Ratings, Litigation & Regulatory Alerts for Tuhi Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Tuhi Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Tuhi Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Tuhi Life Sciences Private Limited
Tuhi Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAGCT5126R1ZX | Madhya Pradesh | Active | 14 Jan 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Tuhi Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tuhi Life Sciences Private Limited
Tuhi Life Sciences is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 November 2017 (9+ years old) and is registered under CIN U74999MP2017PTC044531.
Tuhi Life Sciences reported revenue of ₹78.19 Lakh for FY 2025 (up 11% YoY).
Tuhi Life Sciences has 2 current directors:
- Satvinder Kaur - Director
- Gurpreet Singh - Director
Tuhi Life Sciences reported a net profit of ₹64,840 (net margin 0.8%) and EBITDA of ₹1.31 Lakh (EBITDA margin 1.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Tuhi Life Sciences is 11% over three years and 26% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Tuhi Life Sciences is 23AAGCT5126R1ZX, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Tuhi Life Sciences is U74999MP2017PTC044531. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tuhi Life Sciences was incorporated on 20 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Tuhi Life Sciences by revenue are Synergy Biopharma P Ltd, Vittarthaa Life Sciences Private Limited, Century Drugs Private Limited, Cedimed Life Science Private Limited, Hyderabad Medicine Private Limited and 5 more, all in the Pharma industry (Formulations).
Gurpreet Singh ceased to be Additional Director on 29 Sep 2025. Komal Preet Kaur ceased to be Director on 03 Jun 2025. Gurpreet Singh was appointed as Director on 01 Jun 2025. Tuhi Life Sciences has 5 board changes on record in total.
The registered office of Tuhi Life Sciences is at 861 Agrawal Nagar, Indore, Madhya Pradesh, India – 452001.